Serum cytokine detection in the clinical follow up of patients with cystic echinococcosis

Clinical and Experimental Immunology

Volumn 115, Issue 3, 1999, Pages 503-507

  Rigano R ^a   Profumo, E ^a   Ioppolo, S ^a   Notargiacomo, S ^a   Teggi, A ^a   Siracusano, Alessandra ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Chemotherapy; Cystic echinococcosis; Follow up; Serum Th1 Th2 cytokines

Indexed keywords

ALBENDAZOLE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ECHINOCOCCOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ALBENDAZOLE; ANTICESTODAL AGENTS; CYTOKINES; ECHINOCOCCOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS;

EID: 0032996324     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00843.x     Document Type: Article

References (15)

1. Riganò R, Profumo E, Di Felice G et al. In vitro production of cytokines by peripheral blood mononuclear cells from hydatid patients. Clin Exp Immunol 1995; 99:433-9.
2. Teggi A, Lastilla MG, De Rosa F. Therapy of human hydatid disease with Mebendazole and Albendazole. Antimicrob Agents Chemother 1993; 37:1679-84.
3. Horton RJ. Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Med Hyg 1989; 83:97-102.
4. Todorov T, Vutova K, Mechkov G et al. Evaluation of response to chemotherapy of human cystic echinococcosis. Br J Radiol 1990; 63:523-31.
5. Wen H, New RRC, Craig PS. Diagnosis and treatment of human hydatidosis. Br J Clin Pharm 1993; 35:565-74.
6. Pawloski Z, Dar FK, Eckert J, Kern P. Guidelines for treatment of cystic and alveolar Echinococcosis in human. Report of WHO Informal Group Meeting October 19 1994. Geneva: WHO, 1994.
7. Riganò R, Profumo E, Ioppolo S et al. Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Clin Exp Immunol 1995; 102:281-5.
8. Riganò R, Profumo E, Teggi A et al. Production of IL-5 and IL-6 by peripheral blood mononuclear cell (PBMC) from patients with Echinococcus granulosus infection. Clin Exp Immunol 1996; 105:456-9.
9. Torcal J, Navarro-Zorraquino M, Lozano R et al. Immune response and in vivo production of cytokines in patients with liver hydatidosis. Clin Exp Immunol 1996; 106:317-22.
10. Touil-Boukoffa C, Sanceau J, Tayebi B et al. Relationship among circulating interferon, tumor necrosis factor-α and interleukin-6 and serologic reaction against parasitic antigen in human hydatidosis. J Interferon Cytokine Res 1997; 17:211-7.
11. WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bull World Health Org 1996; 74:231-42.
12. Caremani M, Benci A, Maestrini R et al. Abdominal cystic hydatid disease (CHD): classification of sonographic appearance and response to treatment. J Clin Ultrasound 1996; 24:491-500.
13. Siracusano A, Ioppolo S, Notargiacomo S et al. Detection of antibodies against Echinococcus granulosus major antigens and their subunits by immunoblotting. Transr Soc Trop Med Hyg 1991; 85:239-43.
14. Aceti A, Celestino D, Teggi A et al. Histamine release test in the diagnosis of human hydatidosis. Clin Exp Allergy 1989; 19:335-9.
15. Chinnery JB, Morris DL. Effect of albendazole sulphoxide on viability of hydatid protoscoleces in vitro. Trans R Soc Trop Med Hyg 1986; 80:815-7.